# Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

> **NCT02667886** · PHASE1,PHASE2 · COMPLETED · sponsor: **X4 Pharmaceuticals** · enrollment: 74 (actual)

## Conditions studied

- Clear Cell Renal Cell Carcinoma

## Interventions

- **DRUG:** X4P-001
- **DRUG:** axitinib

## Key facts

- **NCT ID:** NCT02667886
- **Lead sponsor:** X4 Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-27
- **Primary completion:** 2022-04-14
- **Final completion:** 2022-04-14
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02667886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02667886, "Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02667886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*